Are you involved in bringing groundbreaking medical technologies to clinical practice? Do you find that traditional Health Technology Assessments (HTAs) often fall short, with their findings sometimes having limited impact on practical implementation and coverage decisions? This common challenge arises because conventional HTAs are frequently based on the unrealistic assumption of stability of both the technology and its environment – a “ceteris paribus” principle that rarely holds true in the rapidly evolving healthcare landscape. As a result, HTA studies can produce outdated evaluations by the time their findings are published, hindering the development of optimal implementation guidelines.
A Paradigm Shift: Embracing Technology Dynamics
Published in the International Journal of Technology Assessment in Health Care, the article “Methodology of constructive technology assessment in health care” by Douma, Karsenberg, Hummel, Bueno-de-Mesquita, and Van Harten, introduces Constructive Technology Assessment (CTA) as a powerful complementary approach to address these critical gaps. First described in the 1980s outside of healthcare, CTA has evolved into a broader methodology that goes beyond merely assessing impact to include the analysis of a new technology’s design, development, and implementation.
What Makes CTA Unique and Effective?
Unlike traditional HTAs, CTA explicitly takes into account technology dynamics by emphasizing sociodynamic processes. Its core objective is to combine comprehensive assessment with an intentional influence in a favorable direction to improve quality and ultimately lead to a more effective technology in clinical practice.
Key features and benefits of the CTA methodology include:
- Early Intervention: CTA starts before a new technology has even been introduced into clinical practice, ideally taking into account the dynamics of every separate development phase. This early engagement contrasts with traditional HTAs that often evaluate well-developed technologies.
- Dynamic Focus: It recognizes that both the technology and its environment are constantly changing. CTA researchers are equipped to react to changes made, intentionally or unintentionally, to the technology or its surrounding environment. The focus shifts from merely studying quality to optimizing the technology’s quality and effectiveness under dynamic circumstances.
- Comprehensive Scope: While HTAs broadly aim to include organizational, social, economic, and ethical considerations, CTA’s dynamic view makes it more likely that all relevant aspects will actually be covered. These aspects include:
- Clinical: Efficacy, safety, effectiveness, outcomes, and population impact.
- Economic: Cost-effectiveness.
- Patient-related: Social and environmental impact, ethics, acceptability, psychological reactions, and patient-centeredness.
- Organizational: Diffusion, dissemination, implementation, accessibility/equity, skills/routines, education/training.
- Adaptive Methodology: The method and design are flexible, determined by the technology’s nature (e.g., hard, soft, or mixed technologies), its stage of development, and the aspects included. CTA typically uses a combination of several additional or concurrent research methods, including social science techniques, sociotechnical mapping, process analysis, patient satisfaction, impact measurement, and various forms of cost-effectiveness analysis. Action research and scenario methods are particularly appropriate for studying dynamic processes and influencing technological development.
- Continuous Feedback and Optimization: CTA monitors implementation through various diffusion stages, identifying needs for intermediate evaluation or intervention. By giving feedback on evaluated findings as they are collected (from researchers, patients, or professionals), more effective implementation can be significantly enhanced.
A Real-World Example: Microarray Analysis in Breast Cancer
The article illustrates CTA’s methodology through a compelling case study: the controlled introduction of microarray analysis for breast cancer treatment. This innovative 70-gene profile, which predicts survival chances more accurately than traditional factors, was in an early stage of development (innovation/early adopter phase). Given the expected 10-year timeline for conventional introduction, a controlled approach with CTA was deemed appropriate and vital to ensure and improve the quality of implementation.
In this case, CTA actively studied aspects such as patient centeredness, user friendliness, timing, efficiency/efficacy, juridical and ethical considerations, safety, and cost-effectiveness throughout the implementation process, paying special attention to how these factors change over time. This practical application demonstrates how CTA guides the development of effective implementation guidelines and can lead to a cost-effectiveness study when sufficient data is gathered.
Conclusion: A Faster, Smarter Path to Quality Healthcare Innovations
CTA is especially suitable for promising technologies in an early stage of development, particularly when there is uncertainty about their course of development or an expected dynamic interaction between technology and its environment. It is highly relevant for innovations that qualify for early or conditional coverage decisions.
By combining speed with carefulness, CTA offers a practical and robust method to evaluate and guide the introduction of new health technologies. It provides the impetus for a more direct influence on policy making, serving as an essential complementary approach to traditional HTA.
Reference for this article:
Douma, K. F. L., Karsenberg, K., Hummel, M. J. M., Bueno-de-Mesquita, J. M., & Van Harten, W. H. (2007). Methodology of constructive technology assessment in health care. International Journal of Technology Assessment in Health Care, 23(2), 162–168. doi:10.1017/S0266462307070262